21 results
P
STEMI, NSTE-ACS
I/C
dual antiplatelet therapy (DAPT), standard DAPT (12 months) with clopidogrel or potent P2Y
O
NACE
P
Type 2 diabetes mellitus (T2DM) individuals
I/C
IL1β, controls
O
limited evidence available to implicate IL1β as a potent biomarker for T2DM
P
31,230
I/C
TMAO, Highest category of TMAO vs. lowest category
O
Mortality hazard ratio (HR) increased by 47%
P
humans
I/C
tomato intake, lycopene intake, no tomato intake, low lycopene intake
O
all-cause mortality, coronary heart disease mortality, cerebrovascular disease mortality, prostate cancer, gastric cancer, stroke, cardiovascular disease, metabolic syndrome, male infertility
P
adult patients
I/C
tocotrienol supplementation, no tocotrienol supplementation
O
lipid profile (HDL-C, LDL-C, TC, TG)
P
healthy participants (n = 929)
I/C
administration of a public speech task, sex differences
O
HRV
P
maize, winter wheat, rice, tea plantations, fruit orchards
I/C
nitrogen fertilizer input, organic substitution with chemical fertilizers, enhanced-efficiency nitrogen fertilizers, biochar
O
NO emissions
P
honey, propolis, acyclovir
I/C
honey, propolis, acyclovir
O
healing property, healing time, pain reduction
P
patients with chronic myeloid leukemia (CML)
I/C
ponatinib, a third-generation TKI, current first-line TKIs
O
effectiveness, feasibility, and safety of ponatinib in real-life clinical management of CML
P
children, patients with mild-to-moderate atopic dermatitis
I/C
pimecrolimus, vehicle, tacrolimus, topical corticosteroids
O
Investigator's Global Assessment (IGA) score 0/1 up to week 6, adverse events